Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susan Stalter"'
Autor:
Roderich E. Schwarz, George Somlo, Timothy W. Synold, Bixin Xi, Yun Yen, Paul Frankel, Robert J. Morgan, James H. Doroshow, Warren Chow, Mariana Koczywas, Benjamin Paz, David Chu, Kim Margolin, Susan Stalter, Przemyslaw Twardowski, Lawrence D. Wagman, Lucille Leong, Merry Tetef, Stephen Shibata, Dean Lim, Paul Lin
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(4)
Purpose: To determine the maximally tolerated dose, toxicity, and pharmacokinetics of i.p. gemcitabine. Experimental Design: Patients had peritoneal carcinomatosis. Gemcitabine (40, 80, 120, or 160 mg/m2) was administered into the peritoneal cavity i
Autor:
Przemyslaw Twardowski, George Somlo, Warren Chow, Jeffrey Schriber, Neil Kogut, Susan Stalter, Lucille Leong, Yun Yen, James H. Doroshow, Mark McNamara, Paul Frankel, Robert J. Morgan, Kim Margolin, Joseph C. Alvarnas, Dean Lim, Stephen Shibata
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(11)
We evaluated the antitumor activity of tandem cycles of high-dose chemotherapy with autologous peripheral stem cell transplantation (aPSCT) in relapsed germ cell tumors by using high-dose paclitaxel, carboplatin, etoposide, and ifosfamide. Thirty-thr
Autor:
Robert J, Morgan, James H, Doroshow, Timothy, Synold, Dean, Lim, Stephen, Shibata, Kim, Margolin, Roderich, Schwarz, Lucille, Leong, George, Somlo, Przemyslaw, Twardowski, Yun, Yen, Warren, Chow, Paul, Lin, Benjamin, Paz, David, Chu, Paul, Frankel, Susan, Stalter
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(16 Pt 1)
The purpose of this Phase I study was to determine the maximum tolerated dose and dose-limiting toxicities (DLTs) of i.p. docetaxel and to determine the peritoneal pharmacokinetics and pharmacological advantage of this agent.Twenty-one patients with
Autor:
Gwendolyn Fyfe, Daniel C. Adelman, J. Gaudreault, Kim Margolin, Eric Holmgren, Michael S. Gordon, J. Breed, Susan Stalter, William Novotny
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(3)
PURPOSE: Tumor angiogenesis mediated by vascular endothelial growth factor (VEGF) is inhibited by the recombinant humanized (rhu) monoclonal antibody (MAb) rhuMAbVEGF, which has synergy with chemotherapy in animal models. The present study was design
Autor:
E. Holmgren, S. Shak, R. Benjamin, Susan Stalter, George W. Sledge, Michael S. Gordon, Kim Margolin, M. Talpaz, Daniel C. Adelman
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(3)
PURPOSE: We investigated the safety and pharmacokinetics of a recombinant human monoclonal antibody to vascular endothelial growth factor (rhuMAb VEGF) in patients with cancer. PATIENTS AND METHODS: Cohorts of patients with metastatic cancer having f